Trevena, Inc. (TRVN)
NASDAQ: TRVN · IEX Real-Time Price · USD
0.238
-0.007 (-3.02%)
At close: Jul 19, 2024, 4:00 PM
0.240
+0.002 (0.84%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Trevena Market Cap
Trevena has a market cap or net worth of $4.37 million as of July 22, 2024. Its market cap has decreased by -55.91% in one year.
Market Cap
4.37M
Enterprise Value
-14.53M
1-Year Change
-55.91%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from $145.40M to $4.37M, a decrease of -97.00%. That is a compound annual growth rate of -28.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.40M | -60.00% |
| Dec 29, 2023 | 11.00M | 11.11% |
| Dec 30, 2022 | 9.90M | -89.67% |
| Dec 31, 2021 | 95.80M | -71.49% |
| Dec 31, 2020 | 336.00M | 331.32% |
| Dec 31, 2019 | 77.90M | 120.06% |
| Dec 31, 2018 | 35.40M | -64.49% |
| Dec 29, 2017 | 99.70M | -67.60% |
| Dec 30, 2016 | 307.70M | -42.28% |
| Dec 31, 2015 | 533.10M | 237.83% |
| Dec 31, 2014 | 157.80M | 8.53% |
| Jan 31, 2014 | 145.40M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 4.53M |
| Predictive Oncology | 4.47M |
| Genetic Technologies | 4.47M |
| Sonnet BioTherapeutics Holdings | 4.44M |
| Hoth Therapeutics | 4.41M |
| Allarity Therapeutics | 4.30M |
| MyMD Pharmaceuticals | 4.25M |
| CERo Therapeutics Holdings | 4.17M |